Recent Posts
- Health Canada has approved an updated version of the NITISINONE TABLETS’ Product Monograph
- Cycle Pharmaceuticals and Catalent Partner to Develop Treatments for Rare Diseases using Zydis ODT Technology
- NITYR (nitisinone) Tablets for tyrosinaemia type 1 will be available with fully subsidised access on the Life Saving Drugs Program across Australia
- Cycle Pharmaceuticals’ NITYR (nitisinone) tablets receives marketing authorization in Chile
- Longer shelf life for NITYR (nitisinone) tablets for HT-1 in the U.S. granted by the FDA
Archives
- No comments have been published yet.
Find us on Facebook
Archives
Recent Posts
- Health Canada has approved an updated version of the NITISINONE TABLETS’ Product Monograph
- Cycle Pharmaceuticals and Catalent Partner to Develop Treatments for Rare Diseases using Zydis ODT Technology
- NITYR (nitisinone) Tablets for tyrosinaemia type 1 will be available with fully subsidised access on the Life Saving Drugs Program across Australia
- Cycle Pharmaceuticals’ NITYR (nitisinone) tablets receives marketing authorization in Chile
- Longer shelf life for NITYR (nitisinone) tablets for HT-1 in the U.S. granted by the FDA
Recent Tweets
-
Say hello to Avada Bakery bit.ly/2Pg97gR Beautifully designed with elegant styling, & flexible to match yo… twitter.com/i/web/status/1…
22 hours ago -
@coenietje Rule of thumb would be to update the theme first, always make backups of the theme, plugins, & database.… twitter.com/i/web/status/1…
23 hours ago -
@HalveZool348 Send us an email to support@theme-fusion.com detailing what you need and any questions you have, and we will be glad to help.
23 hours ago
Recent Comments